Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 18.39 CNY -5.35% Market Closed
Market Cap: 16.5B CNY
Have any thoughts about
Autek China Inc?
Write Note

Autek China Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Autek China Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Autek China Inc
SZSE:300595
Additional Paid In Capital
ÂĄ1.2B
CAGR 3-Years
177%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Additional Paid In Capital
ÂĄ2.7B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Additional Paid In Capital
ÂĄ4.1B
CAGR 3-Years
0%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Additional Paid In Capital
ÂĄ4.4B
CAGR 3-Years
-1%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
-6%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
-9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Autek China Inc
Glance View

Market Cap
16.5B CNY
Industry
Health Care

Ovctek China, Inc. engages in the operation of eye vision technology. The company is headquartered in Hefei, Anhui and currently employs 2,772 full-time employees. The company went IPO on 2017-01-17. The firm's main business is non-surgical vision correction. The firm's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The firm mainly operates its business in the domestic market.

Intrinsic Value
22.45 CNY
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Autek China Inc's Additional Paid In Capital?
Additional Paid In Capital
1.2B CNY

Based on the financial report for Sep 30, 2024, Autek China Inc's Additional Paid In Capital amounts to 1.2B CNY.

What is Autek China Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
39%

Over the last year, the Additional Paid In Capital growth was -4%. The average annual Additional Paid In Capital growth rates for Autek China Inc have been 177% over the past three years , 39% over the past five years .

Back to Top